Abstract
In vitro experiments demonstrate the high affinity of the toxic convulsant norbornan [2,2-di-(trifluoromethyl)-3,3-dicyano-5,6-dichloronorbornane] for the GABAA-receptor chloride channels of membranes from rat brain. Repeated washing and centrifugation do not restore the ionophore density on norbornan-treated membranes, suggesting that norbornan may be counted among the agents acylating the chloride channels.
Similar content being viewed by others
References
V. D. Gladkikh, N. A. Kolosova, and N. A. Loshadkin, in:Current Topics Related to the Development of Medical Means and Methods of Preserving and Restoring Combat Efficiency in Armed Forces Personnel [in Russian], Moscow (1994), pp. 100–101.
A. I. Golovko and G. A. Sofronov,Byull. Eksp. Biol. Med.,113, No. 2, 155–156 (1992).
S. A. Kutsenko, V. A. Chepurnov, V. P. Fedonyuk,et al., in: War Medicine. Problems of Prophylaxis, Diagnosis, and Treatment of Critical States [in Russian], Moscow (1994), pp. 159–168.
J. E. Casida, C. J. Palmer, and L. M. Cole,Mol. Pharmacol.,28, No. 3, 246–253 (1985).
B. R. de Costa, A. H. Lewin, K. C. Rice,et al., J. Med. Chem.,34, No. 5, 1531–1538 (1991).
M. Farrant and R. A. Webster, in:Drugs as Tools in Neurotransmitter Research, New York (1989), pp. 161–201.
J. E. Hawkinson, M. P. Goeldner, C. J. Palmer, and J. E. Casida,J. Recept. Res.,11, No. 1-4, 391–405 (1991).
A. H. Lewin, B. R. de Costa, K. C. Rice, and P. Skolnik,Mol. Pharmacol.,35, No. 2, 189–194 (1989).
E. J. Moody, A. H. Lewin, B. R. de Costa,et al., Eur. J. Pharmacol.,206, No. 2, 113–118 (1991).
F. A. Stephenson,J. Recept. Res.,7, No. 1-4, 43–54 (1987).
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 121, No. 4, pp. 444–446, April, 1996
Rights and permissions
About this article
Cite this article
Golovko, A.I., Sofronov, G.A. & Klyuntina, T.V. Norbornan, a new irreversible ligand of the GABAA-receptor chloride channels. Bull Exp Biol Med 121, 404–406 (1996). https://doi.org/10.1007/BF02446741
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02446741